Parallel Advisors’s Tango Therapeutics TNGX Stock Holding History

Parallel Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$125	Buy	+5	New	+$130	﹤0.01%	3967

Other funds holding TNGX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Mass General Brigham Somerville, Massachusetts $456M AUM 27.51% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Parallel Advisors's TNGX Position: Q3 2026 in Review

Parallel Advisors opened a new position in Tango Therapeutics (TNGX) in Q3 2026: 5 shares worth $125. The stake represents ﹤0.01% of the portfolio and ranks #3967 among its holdings.

57 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

Parallel Advisors held 5 shares of Tango Therapeutics worth $125 as of Q3 2026.
Tango Therapeutics was a new Parallel Advisors position in Q3 2026.
Tango Therapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3967 holding.
57 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.